Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma. [electronic resource]
Producer: 20060213Description: 7462-9 p. digitalISSN:- 1078-0432
- Adenocarcinoma -- genetics
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Barrett Esophagus -- genetics
- Calmodulin-Binding Proteins -- genetics
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- DNA-Binding Proteins -- genetics
- Esophageal Neoplasms -- genetics
- Esophagectomy
- Female
- Fluorouracil -- administration & dosage
- Gene Expression Regulation, Neoplastic
- Humans
- Male
- Methylenetetrahydrofolate Reductase (NADPH2) -- genetics
- Middle Aged
- Multidrug Resistance-Associated Proteins -- genetics
- Neoadjuvant Therapy
- Paclitaxel -- administration & dosage
- RNA, Messenger -- genetics
- Receptor, ErbB-2 -- genetics
- Reverse Transcriptase Polymerase Chain Reaction -- methods
- Survival Analysis
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.